Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr 21;14(9):1723.
doi: 10.3390/nu14091723.

Omega-3 Fatty Acids and Their Interaction with the Gut Microbiome in the Prevention and Amelioration of Type-2 Diabetes

Manoj Kumar  1 , Namrata Pal  1 , Poonam Sharma  1 , Manoj Kumawat  1 , Devojit Kumar Sarma  1 , Bilkees Nabi  2 , Vinod Verma  3 , Rajnarayan R Tiwari  1 , Swasti Shubham  1 , Bahram Arjmandi  4 , Ravinder Nagpal  4
Affiliations
Review

Omega-3 Fatty Acids and Their Interaction with the Gut Microbiome in the Prevention and Amelioration of Type-2 Diabetes

Manoj Kumar et al. Nutrients. .

Abstract

Type-2 diabetes mellitus (T2DM) is often linked with hyperglycemia, disturbed lipid profiles, inflammation, and gut dysbiosis. Omega-3 fatty acid supplementation has a vital role in the management of T2DM. As a result, a better understanding of the potential role of omega-3 fatty acids in the development and progression of T2DM by influencing the intestinal microflora will help to improve the therapeutic intervention for T2DM and related complications. Focusing on the molecular mechanisms and signaling pathways induced by omega-3 fatty acids, this paper attempts to comprehensively review and discuss the putative associations between omega-3 fatty acids, gut dysbiosis, and the pathophysiology of T2DM and its related comorbidities. In addition, we contemplate the importance of gut microbiota in T2DM prevention and treatment and ponder the role of omega-3 fatty acids in T2DM by positively modulating gut microbiota, which may lead to discovery of novel targets and therapeutic strategies thereby paving way for further comprehensive, mechanistic, and clinical studies.

Keywords: alpha-linolenic acid; diabetes mellitus; docosahexaenoic acid; eicosapentaenoic acid; gut; microbiota; omega-3 fatty acids.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
An illustration depicting the relationship between elevated free fatty acids (FFAs) and insulin resistance (IR). (HSL: hormone-sensitive lipase; VLDL: very-low density lipoprotein; LDL: low density lipoprotein; TG: triglycerides).
Figure 2
Figure 2
Diagrammatic depiction of the effect of omega-3 fatty acids (O-3 FAs) on (A) endoplasmic reticulum (ER) and mitochondrial stress, which results in insulin sensitivity, and (B) on gut eubiosis (homeostasis), which results in anti-inflammatory actions [63]. O3: omega-3 fatty acids; EPA: Eicosapentaenoic acid; DHA: docosahexaenoic acid; F/B ratio: Firmicutes-Bacteroidetes ratio; IL: interleukin; DAG: Diacylglycerol; TNF: tumor necrosis factor; SCFA: short-chain fatty acids.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. De Silva K., Demmer R.T., Jonsson D., Mousa A., Forbes A., Enticott J. A data-driven biocomputing pipeline with meta-analysis on high throughput transcriptomics to identify genome-wide miRNA markers associated with type 2 diabetes. Heliyon. 2022;8:e08886. doi: 10.1016/j.heliyon.2022.e08886. - DOI - PMC - PubMed
    1. Valder S., Brinkmann C. Exercise for the Diabetic Gut—Potential Health Effects and Underlying Mechanisms. Nutrients. 2022;14:813. doi: 10.3390/nu14040813. - DOI - PMC - PubMed
    1. McCrimmon R.J., Ryan C.M., Frier B.M. Diabetes and cognitive dysfunction. Lancet. 2012;379:2291–2299. doi: 10.1016/S0140-6736(12)60360-2. - DOI - PubMed
    1. Pantalone K.M., Hobbs T.M., Wells B.J., Kong S.X., Kattan M.W., Bouchard J., Yu C., Sakurada B., Milinovich A., Weng W., et al. Clinical characteristics, complications, comorbidities and treatment patterns among patients with type 2 diabetes mellitus in a large integrated health system. BMJ Open Diabetes Res. Care. 2015;3:e000093. doi: 10.1136/bmjdrc-2015-000093. - DOI - PMC - PubMed
    1. Domingueti C.P., Dusse L.M.S.A., das Graças Carvalho M., de Sousa L.P., Gomes K.B., Fernandes A.P. Diabetes mellitus: The linkage between oxidative stress, inflammation, hypercoagulability and vascular complications. J. Diabetes Its Complicat. 2016;30:738–745. doi: 10.1016/j.jdiacomp.2015.12.018. - DOI - PubMed

MeSH terms

Substances